ClinicalTrials.Veeva

Menu

The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity

The University of Chicago logo

The University of Chicago

Status

Withdrawn

Conditions

MRSA Infection

Treatments

Drug: Placebo
Drug: Sinofresh

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a study to assess the ability of SinoFresh Nasal & Sinus Care, an FDA approved over-the-counter nasal spray, to eliminate the bacteria in your nose.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • The volunteer is able to adhere to the study requirements and study visits.
  • Agrees to abstain from use of other nasal sprays for length of study.
  • Diagnosis of an MRSA carrier by PCR testing

Exclusion criteria

  • History of chronic nose bleeds.
  • History of intranasal steroids in the last 2 months
  • Nasal obstruction severe enough to prohibit effective delivery of a nasal spray
  • Epistaxis
  • Significant excoriation in the opinion of the Investigator.
  • Known hypersensitivity to any ingredients

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups, including a placebo group

2
Placebo Comparator group
Description:
Identical-appearing placebo
Treatment:
Drug: Placebo
1
Active Comparator group
Description:
two sprays in each nostril three times daily for one week
Treatment:
Drug: Sinofresh

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems